A detailed history of Headlands Technologies LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 91,167 shares of ARDX stock, worth $535,150. This represents 0.04% of its overall portfolio holdings.

Number of Shares
91,167
Holding current value
$535,150
% of portfolio
0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$3.92 - $6.64 $357,374 - $605,348
91,167 New
91,167 $503,000
Q1 2025

May 09, 2025

BUY
$4.91 - $6.36 $96,761 - $125,336
19,707 Added 836.46%
22,063 $108,000
Q4 2024

Feb 12, 2025

BUY
$4.49 - $6.85 $10,578 - $16,138
2,356 New
2,356 $12,000
Q2 2023

Aug 03, 2023

BUY
$3.23 - $4.95 $15,898 - $24,363
4,922 Added 2719.34%
5,103 $17,000
Q1 2023

May 01, 2023

BUY
$2.68 - $4.79 $485 - $866
181 New
181 $0

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $908M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.